Charles River Laboratories Intl. Inc vs Abrdn Physical Platinum Shares ETF — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while Abrdn Physical Platinum Shares ETF trades at $16.11. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| CRL | PPLT | |
|---|---|---|
Market Cap | $13.46B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $282.00 | $25.23 |
52-Week Low | $145.57 | $11.95 |
Enterprise Value | $16.30B | — |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →